SUMMARY The serum concentrations of the complement inactivators C1INH, C3bINA and 31H have been determined in patients with ulcerative colitis and Crohn's disease and their correlation with C3 and properdin factor B examined. The incidence of immunoconglutinins (IK) in these patients was investigated. Raised serum concentrations of CTINH and C3bINA have been found in patients with active disease, but no significant alteration was found in serum concentration of 31H. An increasing incidence of positive 1K titres was found with increased length of disease history. These results suggest continuing complement activation in these diseases.
Serum concentrations of several complement components are known to be altered in ulcerative colitis and Crohn's disease. C3 and properdin factor B are raised and may show a positive correlation with disease activity and the extent of the inflammation.12 Less marked changes have been found for C42-4 and no significant change occurs in the serum concentration of Cl q.1 These changes can be interpreted as occurring secondary to acute inflammation. However, direct evidence for increased complement consumption lhas been presented from metabolic studies of purified Clq and c3.6 Furthermore, an increased incidence of conversion products of C3 and properdin factor B has been found.7 8 It is not known whether increased complement activation occurs purely as a result of continuing antigen-antibody reactions or whether there is a defective modulation of the complement cascade. The aim of this study, therefore, was to assay the inhibitors of the complement system and to provide additional evidence of continuing complement activation by measuring the titres of serum immunoconglutinins (which are antibodies to activated complement components). 
Methods

Results
The serum concentrations of C1INH, C3bINA, and with active disease. 1fotter, Brown, Watson, and Jewell 
CORRELATIONS BETWEEN SERUM CONCENTRATIONS
There was no general correlation with any two serum components and inhibitors measured over the entire group of subjects. However, C3bINA did correlate with C3 in Crohn's disease (r=0-418, P <0.01) and with factor B in ulcerative colitis (r=0.527, P <0 01), and control subjects (r= 0 169, P <0.01).
IMMUNOCONGLUTININS
The titres obtained in each group are shown in Table 3 . In both ulcerative colitis and Crohn's disease there was a greater incidence of positive 1K titres (> 1:4) in active disease than in the control subjects (P <0 01). The incidence in remission, however, was within the normal range (Table 4) . When patients were examined for positive 1K titres in relationship to disease history, it was found that both groups showed a similar pattern and are therefore grouped together in Table 5 . From this 
